Rare Neurological Disease Treatment Global Market: Orphan Pharmaceuticals Gaining Popularity
January 05, 2024 21:03 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Rare Neurological Disease Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Rare neurological disease...
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
September 29, 2022 16:01 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Embolotherapy Market to Garner $5.75Bn, Globally, by 2028 Growing at 8.1% CAGR | Exclusive Research by The Insight Partners
August 24, 2022 05:24 ET
|
The Insight Partners
New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Disease...
Worldwide Neurorehabilitation Industry to 2030 - Rising Demand of Telerehabilitation Presents Opportunities
February 17, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Neurorehabilitation Market by Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Neurological Biomarkers Market by Application, by Type, by End-use, by Region and Forecasts to 2028
December 06, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By...
Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial
September 08, 2021 07:00 ET
|
Longboard Pharmaceuticals, Inc.
Favorable safety, tolerability, pharmacokinetics and pharmacodynamics were observed Central 5-HT2c receptor engagement demonstrated by dose- and exposure-dependent increases of prolactin Company...
Outlook on the Neurological Diseases Treatment Global Market to 2029 - Key Drivers, Challenges and Opportunities
April 29, 2021 07:18 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Insights on the Genetic Testing for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions Global Market to 2025
February 15, 2021 05:43 ET
|
Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions" report has been added to ResearchAndMarkets.com's offering. ...
Clinical Biomarkers Market to Reach USD 38.79 Billion By 2027 | Global Analysis, Statistics, Industry Revenue, Demand and Trend Analysis Research Report by Emergen Research
February 11, 2021 11:39 ET
|
Emergen Research
Vancouver, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The global clinical biomarkers market is expected to reach a market size of USD 38.79 billion at a steady CAGR of 10.2% in 2027,...
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
January 20, 2021 16:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...